BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7678906)

  • 1. Mutagenicity to Salmonella, Drosophila and the mouse bone marrow of the human antineoplastic agent fotemustine: prediction of carcinogenic potency.
    Ashby J; Vogel EW; Tinwell H; Callander RD; Shuker DE
    Mutat Res; 1993 Mar; 286(1):101-9. PubMed ID: 7678906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutagenicity to the mouse bone marrow by the mouse germ cell mutagen N-propyl-N-nitrosourea.
    Tinwell H; Yendle J; Ashby J
    Mutat Res; 1996 Oct; 370(3-4):141-3. PubMed ID: 8917659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimutagenicity of amifostine against the anticancer drug fotemustine in the Drosophila somatic mutation and recombination (SMART) test.
    Aydemir N; Sevim N; Celikler S; Vatan O; Bilaloglu R
    Mutat Res; 2009; 679(1-2):1-5. PubMed ID: 19712749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic activity of the human carcinogen sulphur mustard towards Salmonella and the mouse bone marrow.
    Ashby J; Tinwell H; Callander RD; Clare N
    Mutat Res; 1991 May; 257(3):307-11. PubMed ID: 2014034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of the human carcinogen MeCCNU in the mouse bone marrow micronucleus assay.
    Tinwell H; Ashby J
    Environ Mol Mutagen; 1991; 17(3):152-4. PubMed ID: 2022193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotoxicity testing of extracts of a Swedish moist oral snuff.
    Jansson T; Romert L; Magnusson J; Jenssen D
    Mutat Res; 1991 Oct; 261(2):101-15. PubMed ID: 1922153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the rodent micronucleus assay in the screening of IARC carcinogens (groups 1, 2A and 2B) the summary report of the 6th collaborative study by CSGMT/JEMS MMS. Collaborative Study of the Micronucleus Group Test. Mammalian Mutagenicity Study Group.
    Morita T; Asano N; Awogi T; Sasaki YF; Sato S; Shimada H; Sutou S; Suzuki T; Wakata A; Sofuni T; Hayashi M
    Mutat Res; 1997 Feb; 389(1):3-122. PubMed ID: 9062586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTP Technical Report on the Toxicology and Carcinogenesis Studies of Chloral Hydrate (Cas No. 302-17-0) in B6C3F1 mice (Gavage Studies).
    Natl Toxicol Program Tech Rep Ser; 2002 Feb; (502):1-197. PubMed ID: 11965861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA damage and repair in somatic and germ cells in vivo.
    Vogel EW; Natarajan AT
    Mutat Res; 1995 Aug; 330(1-2):183-208. PubMed ID: 7623865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clastogenicity to the mouse bone marrow of the mouse germ cell genotoxin streptozotocin.
    Liegibel U; Tinwell H; Callander RD; Schmezer P; Ashby J
    Mutagenesis; 1992 Nov; 7(6):471-4. PubMed ID: 1474923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential mutagenic activity of IQ (2-amino-3-methylimidazo[4,5-f]quinoline) in Salmonella typhimurium strains in vitro and in vivo, in Drosophila, and in mice.
    Wild D; Gocke E; Harnasch D; Kaiser G; King MT
    Mutat Res; 1985; 156(1-2):93-102. PubMed ID: 3923347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotoxicity testing of methyl tertiary-butyl ether (MTBE) in the Salmonella microsuspension assay and mouse bone marrow micronucleus test.
    Kado NY; Kuzmicky PA; Loarca-PiƱa G; Moiz Mumtaz M
    Mutat Res; 1998 Jan; 412(2):131-8. PubMed ID: 9580226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heritable and cancer risks of exposures to anticancer drugs: inter-species comparisons of covalent deoxyribonucleic acid-binding agents.
    Vogel EW; Barbin A; Nivard MJ; Stack HF; Waters MD; Lohman PH
    Mutat Res; 1998 May; 400(1-2):509-40. PubMed ID: 9685708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An assessment of the genotoxicity of 2-hydroxy-1,4-naphthoquinone, the natural dye ingredient of Henna.
    Kirkland D; Marzin D
    Mutat Res; 2003 Jun; 537(2):183-99. PubMed ID: 12787822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The genotoxicity and carcinogenic potential of gastrofenzin].
    Mirkova E
    Eksp Med Morfol; 1994; 32(3-4):57-68. PubMed ID: 8857033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
    Irwin RD
    Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutagens that are not carcinogens: faulty theory or faulty tests?
    Zeiger E
    Mutat Res; 2001 May; 492(1-2):29-38. PubMed ID: 11377241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of target organs of carcinogenicity for mutagenic and non-mutagenic chemicals.
    Gold LS; Slone TH; Stern BR; Bernstein L
    Mutat Res; 1993 Mar; 286(1):75-100. PubMed ID: 7678909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evaluation of fotemustine as a potential agent for limb perfusion in melanoma.
    Hayes MT; Bartley J; Parsons PG
    Melanoma Res; 1998 Feb; 8(1):67-75. PubMed ID: 9508380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.